A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeut...

AstraZeneca PLC (AZN) has a valuation score of 80/100 (strong), profitability score of 77/100 (strong), financial health score of 61/100 (moderate), Piotroski F-Score of 7/9, Altman Z-Score of 5.69 (safe zone), revenue growth of +9.8% YoY.

Neutral

Analyst Consensus

Strong Buy

Wall Street consensus estimates — not a PMP forecast · Updated Sep 1, 2026

Analyst Recommendations35 analysts · 2026-08-01
13
16
5
Strong Buy 13Buy 16Hold 5Sell 1Strong Sell 0

Recent Market Moves

See all AZN moves →
DateSessionPriceMoveZ-Score
Aug 5Pre-market$163.67+5.17%3.45
Aug 5Regular$160.93+3.41%2.27
Aug 5After-hours$161.33+3.67%2.45
Aug 3Pre-market$156.77-7.59%-5.06
Aug 3Regular$157.88-6.94%-4.62
AstraZeneca PLC (AZN) Valuation & P/E History →AstraZeneca PLC (AZN) Financial Statements →
Share:

Explore More Stocks

AAPLMSFTNVDAGOOGLAMZNMETATSLAJPMWMTVView all stocks →